Epstein-Barr virus persistence and infection of autoreactive plasma cells in synovial lymphoid structures in rheumatoid arthritis

Annals of the Rheumatic Diseases

Volumn 72, Issue 9, 2013, Pages 1559-1568

  Croia, Cristina ^a   Serafini, Barbara ^b   Bombardieri, Michele ^a   Kelly, Stephen ^a   Humby, Frances ^a   Severa, Martina ^b   Rizzo, Fabiana ^b   Coccia, Eliana Marina ^b   Migliorini, Paola ^c   Aloisi, Francesca ^b   Pitzalis, Costantino ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; GRANZYME B; PEPTIDE ANTIBODY; PEPTIDE ANTIBODY VCP 1; PEPTIDE ANTIBODY VCP 2; RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CD4+ CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ECTOPIC LYMPHOID STRUCTURE; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNITY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; OSTEOARTHRITIS; PERSISTENT VIRUS INFECTION; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SEVERE COMBINED IMMUNODEFICIENCY; SYNOVIUM; T LYMPHOCYTE;

AUTOANTIBODIES; B CELLS; INFECTIONS; RHEUMATOID ARTHRITIS;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ARTHRITIS, RHEUMATOID; AUTOIMMUNITY; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOID TISSUE; MALE; MICE; MICE, SCID; MIDDLE AGED; OSTEOARTHRITIS; PLASMA CELLS; SYNOVIAL MEMBRANE; VIRAL LOAD;

EID: 84881476266     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-202352     Document Type: Article

References (55)

1. McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011;365:2205-19.
2. Balandraud N, Meynard JB, Auger I, et al. Epstein-Barr virus load in the peripheral blood of patients with rheumatoid arthritis: accurate quantification using real-time polymerase chain reaction. Arthritis Rheum 2003;48:1223-8. (Pubitemid 36554521)
3. Lunemann JD, Frey O, Eidner T, et al. Increased frequency of EBV-specific effector memory CD8+ T cells correlates with higher viral load in rheumatoid arthritis. J Immunol 2008;181:991-1000.
4. Catalano MA, Carson DA, Slovin SF, et al. Antibodies to Epstein-Barr virus-determined antigens in normal subjects and in patients with seropositive rheumatoid arthritis. Proc Natl Acad Sci USA 1979;76:5825-8. (Pubitemid 10168698)
5. Yokochi T, Yanagawa A, Kimura Y, et al. High titer of antibody to the Epstein-Barr virus membrane antigen in sera from patients with rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol 1989;16:1029-32. (Pubitemid 19234727)
6. Inoue N, Harada S, Miyasaka N, et al. Analysis of antibody titers to Epstein-Barr virus nuclear antigens in sera of patients with Sjogren's syndrome and with rheumatoid arthritis. J Infect Dis 1991;164:22-8.
7. Tosato G, Steinberg AD, Blaese RM. Defective EBV-specific suppressor T-cell function in rheumatoid arthritis. N Engl J Med 1981;305:1238-43. (Pubitemid 12234844)
8. Scotet E, David-Ameline J, Peyrat MA, et al. T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis. J Exp Med 1996;184:1791-800. (Pubitemid 26404470)
9. Klatt T, Ouyang Q, Flad T, et al. Expansion of peripheral CD8+ CD28-T cells in response to Epstein-Barr virus in patients with rheumatoid arthritis. J Rheumatol 2005;32:239-51. (Pubitemid 40209121)
10. Rickinson AB, Kieff E. Epstein-Barr virus. In: Knipe DM, Howley PM, Griffin DE, et al. eds. Fields virology. Philadelphia, PA: Lippincott-Williams & Wilkins Publishers, 2007:2655-700. 3.
11. Thorley-Lawson DA. Epstein-Barr virus: exploiting the immune system. Nat Rev Immunol 2001;1:75-82. (Pubitemid 33741978)
12. Wang H, Nicholas MW, Conway KL, et al. EBV latent membrane protein 2A induces autoreactive B cell activation and TLR hypersensitivity. J Immunol 2006;177:2793-802. (Pubitemid 44277794)
13. Swanson-Mungerson M, Longnecker R. Epstein-Barr virus latent membrane protein 2A and autoimmunity. Trends Immunol 2007;28:213-18. (Pubitemid 46667241)
14. Anzilotti C, Merlini G, Pratesi F, et al. Antibodies to viral citrullinated peptide in rheumatoid arthritis. J Rheumatol 2006;33:647-51.
15. Pratesi F, Tommasi C, Anzilotti C, et al. Deiminated Epstein-Barr virus nuclear antigen 1 is a target of anti-citrullinated protein antibodies in rheumatoid arthritis. Arthritis Rheum 2006;54:733-41.
16. Serafini B, Rosicarelli B, Franciotta D, et al. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med 2007;204:2899-912. (Pubitemid 350179559)
17. Cavalcante P, Serafini B, Rosicarelli B, et al. Epstein-Barr virus persistence and reactivation in myasthenia gravis thymus. Ann Neurol 2010;67:726-38.
18. Lassmann H, Niedobitek G, Aloisi F, et al. Epstein-Barr virus in the multiple sclerosis brain: a controversial issue-report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria. Brain 2011;134:2772-86.
19. Kakalacheva K, Maurer MA, Tackenberg B, et al. Intrathymic Epstein-Barr virus infection is not a prominent feature of myasthenia gravis. Ann Neurol 2011;70:508-14.
20. Meyer M, Hols AK, Liersch B, et al. Lack of evidence for Epstein-Barr virus infection in myasthenia gravis thymus. Ann Neurol 2011;70:515-8.
21. Brousset P, Caulier M, Cantagrel A, et al. Absence of Epstein-Barr virus carrying cells in synovial membranes and subcutaneous nodules of patients with rheumatoid arthritis. Ann Rheum Dis 1993;52:608-9. (Pubitemid 23246666)
22. Takei M, Mitamura K, Fujiwara S, et al. Detection of Epstein-Barr virus-encoded small RNA 1 and latent membrane protein 1 in synovial lining cells from rheumatoid arthritis patients. Int Immunol 1997;9:739-43. (Pubitemid 27226397)
23. Niedobitek G, Lisner R, Swoboda B, et al. Lack of evidence for an involvement of Epstein-Barr virus infection of synovial membranes in the pathogenesis of rheumatoid arthritis. Arthritis Rheum 2000;43:151-4. (Pubitemid 30368224)
24. Blaschke S, Schwarz G, Moneke D, et al. Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis. J Rheumatol 2000;27:866-73. (Pubitemid 30389739)
25. Mehraein Y, Lennerz C, Ehlhardt S, et al. Latent Epstein-Barr virus (EBV) infection and cytomegalovirus (CMV) infection in synovial tissue of autoimmune chronic arthritis determined by RNA-and DNA-in situ hybridization. Mod Pathol 2004;17:781-9. (Pubitemid 38843360)
26. Takemura S, Braun A, Crowson C, et al. Lymphoid neogenesis in rheumatoid synovitis. J Immunol 2001;167:1072-80. (Pubitemid 32660867)
27. Humby F, Bombardieri M, Manzo A, et al. Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLoS Med 2009;6:e1.
28. Scheel T, Gursche A, Zacher J, et al. V-region gene analysis of locally defined synovial B and plasma cells reveals selected B cell expansion and accumulation of plasma cell clones in rheumatoid arthritis. Arthritis Rheum 2011;63:63-72.
29. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24. (Pubitemid 18091653)
30. Krenn V, Morawietz L, Burmester GR, et al. Synovitis score: discrimination between chronic low-grade and high-grade synovitis. Histopathology 2006;49:358-64. (Pubitemid 44401542)
31. Tak PP, Thurkow EW, Daha MR, et al. Expression of adhesion molecules in early rheumatoid synovial tissue. Clin Immunol Immunopathol 1995;77:236-42.
32. Kraan MC, Haringman JJ, Post WJ, et al. Immunohistological analysis of synovial tissue for differential diagnosis in early arthritis. Rheumatology (Oxford) 1999;38:1074-80. (Pubitemid 29537326)
33. Serafini B, Severa M, Columba-Cabezas S, et al. Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation. J Neuropathol Exp Neurol 2010;69:677-93.
34. Pratesi F, Tommasi C, Anzilotti C, et al. Antibodies to a new viral citrullinated peptide, VCP2: fine specificity and correlation with anti-cyclic citrullinated peptide (CCP) and anti-VCP1 antibodies. Clin Exp Immunol 2011;164:337-45.
35. Gulley ML, Tang W. Laboratory assays for Epstein-Barr virus-related disease. J Mol Diagn 2008;10:279-92. (Pubitemid 352022708)
36. Farina A, Santarelli R, Gonnella R, et al. The BFRF1 gene of Epstein-Barr virus encodes a novel protein. J Virol 2000;74:3235-44. (Pubitemid 30143748)
37. Hislop AD, Ressing ME, van Leeuwen D, et al. A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in old world primates. J Exp Med 2007;204:1863-73. (Pubitemid 47236322)
38. Ewen CL, Kane KP, Bleackley RC. A quarter century of granzymes. Cell Death Differ 2011;19:28-35.
39. Wagner UG, Kurtin PJ, Wahner A, et al. The role of CD8+ CD40L+ T cells in the formation of germinal centers in rheumatoid synovitis. J Immunol 1998;161:6390-7. (Pubitemid 28536016)
40. Kang YM, Zhang X, Wagner UG, et al. CD8T cells are required for the formation of ectopic germinal centers in rheumatoid synovitis. J Exp Med 2002;195:1325-36. (Pubitemid 34564334)
41. Namekawa T, Wagner UG, Goronzy JJ, et al. Functional subsets of CD4T cells in rheumatoid synovitis. Arthritis Rheum 1998;41:2108-16. (Pubitemid 29009368)
42. Appay V, Zaunders JJ, Papagno LS, et al. Characterization of CD4(+) CTLs ex vivo. J Immunol 2002;168:5954-8.
43. Appay V. The physiological role of cytotoxic CD4(+) T-cells: the holy grail? Clin Exp Immunol 2004;138:10-13. (Pubitemid 39279959)
44. Toussirot E, Roudier J. Epstein-Barr virus in autoimmune diseases. Best Pract Res Clin Rheumatol 2008;22:883-96.
45. Takeda T, Mizugaki Y, Matsubara L, et al. Lytic Epstein-Barr virus infection in the synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum 2000;43:1218-25. (Pubitemid 30416306)
46. Klimiuk PA, Goronzy JJ, Bjor nsson J, et al. Tissue cytokine patterns distinguish variants of rheumatoid synovitis. Am J Pathol 1997;151:1311-19. (Pubitemid 27479761)
47. Weyand CM, Goronzy JJ. Ectopic germinal center formation in rheumatoid synovitis. Ann N Y Acad Sci 2003;987:140-9. (Pubitemid 36584016)
48. Kuppers R. B cells under influence: transformation of B cells by Epstein-Barr virus. Nat Rev Immunol 2003;3:801-12. (Pubitemid 37328658)
49. Pender MP. Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases. Trends Immunol 2003;24:584-8. (Pubitemid 37338526)
50. Tracy SI, Kakalacheva K, Lünemann J, et al. Persistence of Epstein-Barr virus in self-reactive memory B cells. J Virol 2012;86:12330-40.
51. Sabbatini A, Bombardieri S, Migliorini P. Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of SmD and Epstein-Barr virus-encoded nuclear antigen EBNA I. Eur J Immunol 1993;23:1146-52. (Pubitemid 23120179)
52. Lunemann JD, Munz C. Epstein-Barr virus and multiple sclerosis. Curr Neurol Neurosci Rep 2007;7:253-8. (Pubitemid 46831520)
53. Hislop AD, Taylor GS, Sauce D, et al. Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annu Rev Immunol 2007;25:587-617. (Pubitemid 46697918)
54. Griffiths GM, Alpert S, Lambert E, et al. Perforin and granzyme a expression identifying cytolytic lymphocytes in rheumatoid arthritis. Proc Natl Acad Sci USA 1992;89:549-53.
55. Kuwana Y, Takei M, Yajima M, et al. Epstein-Barr virus induces erosive arthritis in humanized mice. PLoS One 2011;6:e26630.